Articles

Life sciences considerations for investment treaty disputes

August 26, 2024
DNA, life science, genetics

This article was published in The Investment Treaty Arbitration Review

Greg Bell, Andrew Tepperman, and Justin Ho co-authored a chapter in the ninth edition of The Investment Treaty Arbitration Review.  The chapter titled “Investment Treaty Disputes in the Life Sciences Industry” addresses the features and incentives of the life sciences industry as they lead to tensions and disputes between governments and companies.  The chapter further discusses valuation considerations for practitioners and future issues arising from current developments in the life sciences industry.

Related capabilities

Key contacts